BACKGROUND: Thermal stability signatures of complex molecular interactions in biological fluids can be measured using differential scanning calorimetry (DSC). Evaluating the thermal stability of plasma proteomes offers a method of producing a disease-specific "signature" (thermogram) in neoplastic and autoimmune diseases. OBJECTIVE: The authors describe the use of DSC with human brain tumor tissue to create unique thermograms for correlation with histological tumor classification. METHODS: Primary brain tumors were classified according to the World Health Organization classification. Tumor samples were digested and assayed by a DSC calorimeter. Experimental thermograms were background subtracted and normalized to the total area of transitions to exclude concentration effects. The resulting thermograms were analyzed by applying 2-state, scaled, Gaussian distributions. RESULTS: Differences in glioma-specific signatures are described by using calculated parameters at transitions that are characterized, in the equilibrium approximation, by a melting temperature (Tm), an apparent enthalpy change (ΔH), and a scaling factor related to the relative abundance of the materials denatured in the transition (Aw). Thermogram signatures of glioblastoma multiforme and low-grade astrocytomas were differentiated by calculated values of Aw3 and Tm4, those of glioblastoma multiforme and oligodendrogliomas were differentiated by Aw2, ΔH2, ΔH4, and Tm4, and those of low-grade astrocytomas and oligodendroglioma were differentiated by Aw4. CONCLUSION: Our preliminary results suggest that solid brain tumors exhibit specific thermogram profiles that are distinguishable among glioma grades. We anticipate that our results will form the conceptual base of a novel diagnostic assay based on tissue thermograms as a complement to currently used histological analysis.
BACKGROUND: Thermal stability signatures of complex molecular interactions in biological fluids can be measured using differential scanning calorimetry (DSC). Evaluating the thermal stability of plasma proteomes offers a method of producing a disease-specific "signature" (thermogram) in neoplastic and autoimmune diseases. OBJECTIVE: The authors describe the use of DSC with humanbrain tumor tissue to create unique thermograms for correlation with histological tumor classification. METHODS:Primary brain tumors were classified according to the World Health Organization classification. Tumor samples were digested and assayed by a DSC calorimeter. Experimental thermograms were background subtracted and normalized to the total area of transitions to exclude concentration effects. The resulting thermograms were analyzed by applying 2-state, scaled, Gaussian distributions. RESULTS: Differences in glioma-specific signatures are described by using calculated parameters at transitions that are characterized, in the equilibrium approximation, by a melting temperature (Tm), an apparent enthalpy change (ΔH), and a scaling factor related to the relative abundance of the materials denatured in the transition (Aw). Thermogram signatures of glioblastoma multiforme and low-grade astrocytomas were differentiated by calculated values of Aw3 and Tm4, those of glioblastoma multiforme and oligodendrogliomas were differentiated by Aw2, ΔH2, ΔH4, and Tm4, and those of low-grade astrocytomas and oligodendroglioma were differentiated by Aw4. CONCLUSION: Our preliminary results suggest that solid brain tumors exhibit specific thermogram profiles that are distinguishable among glioma grades. We anticipate that our results will form the conceptual base of a novel diagnostic assay based on tissue thermograms as a complement to currently used histological analysis.
Authors: Philipp O Tsvetkov; Emeline Tabouret; Andrei Y Roman; Sylvie Romain; Céline Bequet; Olga Ishimbaeva; Stéphane Honoré; Dominique Figarella-Branger; Olivier Chinot; François Devred Journal: Oncotarget Date: 2018-01-25
Authors: Nichola C Garbett; Guy N Brock; Jonathan B Chaires; Chongkham S Mekmaysy; Lynn DeLeeuw; Kathy L Sivils; John B Harley; Brad H Rovin; K B Kulasekera; Wael N Jarjour Journal: PLoS One Date: 2017-11-17 Impact factor: 3.240
Authors: Murillo L Martins; Alexander B Dinitzen; Eugene Mamontov; Svemir Rudić; José E M Pereira; Rasmus Hartmann-Petersen; Kenneth W Herwig; Heloisa N Bordallo Journal: Sci Rep Date: 2019-06-18 Impact factor: 4.379
Authors: Shesh N Rai; Sudhir Srivastava; Jianmin Pan; Xiaoyong Wu; Somesh P Rai; Chongkham S Mekmaysy; Lynn DeLeeuw; Jonathan B Chaires; Nichola C Garbett Journal: PLoS One Date: 2019-08-20 Impact factor: 3.240
Authors: Sonia Hermoso-Durán; Guillermo García-Rayado; Laura Ceballos-Laita; Carlos Sostres; Sonia Vega; Judith Millastre; Oscar Sánchez-Gracia; Jorge L Ojeda; Ángel Lanas; Adrián Velázquez-Campoy; Olga Abian Journal: J Pers Med Date: 2020-12-31